Literature DB >> 753482

The relationship between urinary bilharziasis and urolithiasis in the Sudan.

A Ibrahim.   

Abstract

Nine hundred and ninety-seven Sudanese patients presenting to a urological unit in Khartoum were divided into a group consisting of 144 patients with a history or evidence of urinary bilharziasis and a second group of 853 patients with no history or evidence of this disease. Thirty-one per cent of the patients with bilharziasis and 32% of those without were found to have urinary calculi. In the bilharzial group there were recurrent stones in 7% compared with 12.4% in the non-bilharzial group. In the bilharzial group the stones were renal in 63.6%, ureteric in 27.3% and vesical in 9.1%, while in the non-bilharzial group 57% were renal, 30% ureteric and 13% vesical. Comparison of the incidence, rate of recurrence and site of stones in both groups suggests that urinary bilharziasis does not contribute to the high incidence of urolithiasis in the Sudan.

Entities:  

Mesh:

Year:  1978        PMID: 753482     DOI: 10.1111/j.1464-410x.1978.tb03634.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Ultrasonographical aspects of urinary schistosomiasis: assessment of morphological lesions in the upper and lower urinary tract.

Authors:  M Dittrich; E Doehring
Journal:  Pediatr Radiol       Date:  1986

2.  Urolithiasis in Kuwait.

Authors:  N S Khalifa; A A Gabal; M Shihab
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

Review 3.  Urologic complications of genitourinary schistosomiasis.

Authors:  Ismail Khalaf; Ahmed Shokeir; Mohamed Shalaby
Journal:  World J Urol       Date:  2011-09-10       Impact factor: 4.226

4.  Multiple urolithiasis in bilharziasis patients.

Authors:  T Lukács; D Frang; A A el-Seaghy; L Pajor
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 5.  The riddle of kidney stone disease: lessons from Africa.

Authors:  Allen Rodgers
Journal:  Urol Res       Date:  2006-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.